In a study of 62 women at high risk for HIV and 33 low-risk individuals acting as controls (142) secretory leukocyte protease inhibitor (SLPI) levels were lower in women with BV and levels of the chemokine RANTES (CCL5) were higher in the high-risk group. Here, CCL5 is linked to bacterial vaginosis.